LncRNA NORAD Promotes Spinal Cord Injury via miR-22-3p/PTEN Axis to Regulate Oxidative Stress and Inflammation in Neuronal Cells
Zhang C., Chen L., Pan Y., Yu S., Wang Q., Chen Y.
Retrospective Study on Spinal Cord Injury, Neuroinflammation, Chronic Inflammation, published in Global Spine J (2026) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Retrospective Study
- Journal
- Global Spine J (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 42298877
- PMCID
- PMC13272196
- DOI
- 10.1177/21925682261432143
Abstract (original English)
Study DesignRetrospective Study.ObjectiveSpinal cord injury (SCI) is a severe central nervous system trauma. To explore the regulatory mechanism of long non-coding RNA (lncRNA) NORAD in SCI.MethodsEighty healthy controls and 100 SCI patients were enrolled. Meanwhile, SCI animal models and LPS-induced cell models were established. Basso-Beattie-Bresnahan (BBB) scoring was performed to monitor hind-limb motor recovery. The NORAD biological function was evaluated through RT-qPCR, CCK-8 experiments, flow cytometry, enzyme-linked immunosorbent assay (ELISA), and the measurement of oxidative stress and metabolism-related indicators. The targeting relationships were verified through RIP experiments and dual-luciferase experiments.ResultsNORAD exhibited high expression in SCI patients and possessed good diagnostic utility for this disease. Its high expression may also be associated with the severity of injury. In SCI rats, inhibiting NORAD significantly improved the recovery of motor function and alleviated oxidative stress, cellular damage, and neuroinflammation, indicating a pro-injury role of NORAD during SCI pathogenesis. In addition, NORAD was highly expressed in the LPS-induced cell model, and promoted cellular damage, apoptosis, inflammatory responses, and oxidative stress by targeting and inhibiting miR-22-3p. While miR-22-3p directly targeted and inhibited PTEN, which was also
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • Without an adequate control group, treatment effects cannot be separated from other factors.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Host immune determinants of stromal vascular fraction graft survival: Toward a concept of SVF therapy resistance - A systematic narrative review.
Systematic Review on Spinal Cord Injury, Chronic Inflammation, Immune Modulation, published in Cell Transplant (2026) — summary generated from the PubMed abstract.
- 2026
Cell Transplant - Level AMeta-analysisPubMed
Stem cell-derived exosome treatment for acute spinal cord injury: a systematic review and meta-analysis based on preclinical evidence.
Meta-analysis on Spinal Cord Injury, published in Front Neurol (2025) — summary generated from the PubMed abstract.
- 2025
Front Neurol - Level ASystematic ReviewPubMed
Brain-derived neurotrophic factor (BDNF) as biomarker in stem cell-based therapies of preclinical spinal cord injury models: A systematic review.
Systematic Review on Spinal Cord Injury, published in Tissue Cell (2025) — summary generated from the PubMed abstract.
- 2025
Tissue Cell3 citations - Level ASystematic ReviewEurope PMC
Revolutionizing neural regeneration with smart responsive materials: Current insights and future prospects
Systematic Review on Spinal Cord Injury, published in Bioact Mater (2025) — summary generated from the PubMed abstract.
- 2025
Bioact Mater5 citations - Level ASystematic ReviewEurope PMC
Conductive Nanocomposite Hydrogels for Neural Tissue Engineering: A Systematic Scoping Review of Recent Trends
Systematic Review with a reported sample of 42 on Diabetic Foot, Stroke Research, Spinal Cord Injury, Neuroinflammation, published in Adv Sci (Weinh) (2025) — summary generated from the PubMed abstract.
- 2025
- n = 42
Adv Sci (Weinh)18 citations - Level ASystematic ReviewEurope PMC
Emerging regenerative strategies for spinal cord injury: exosome-derived mechanisms and therapeutic insights
Systematic Review on Spinal Cord Injury, Neuroinflammation, published in Front Neurosci (2025) — summary generated from the PubMed abstract.
- 2025
Front Neurosci